Zdrowie i gospodarka · 08/06/2020
FDA to Host Virtual Public Meeting on Reauthorization of Prescription Drug User Fee Act
The FDA is seeking public input on proposed recommendations for reauthorizing the Prescription Drug User Fee Act from FY 2023 to 2027, with a virtual public meeting scheduled to discuss the proposal.